All five handle the mainstream GLP-1s, so "best semaglutide tracker," "best tirzepatide tracker," and apps for Zepbound, Mounjaro, Ozempic, and Wegovy all point to the same shortlist
This slowing contributes to the appetite suppression that drives weight loss and the postprandial glucose-lowering effect, and it also drives most of the gastrointestinal side effect profile.[1],[2] A 2025 review in the Journal of Clinical Endocrinology & Metabolism summarizes the published evidence: GLP-1 receptor agonists impact gastric, intestinal, and gallbladder motility simultaneously, with effects on gastric fundus relaxation, antral contractility inhibition, increased pyloric tone, and reduced small intestinal motility.[3] The path from this mechanism to constipation is straightforward
Research on GLP-1 therapy shows that patients who maintain a fixed injection day report better appetite control and fewer side effects than those who vary their timing by several days
Auris Nasus Larynx 39 , 145150 (2012)
